Interactions of opioid receptors, chemokines, and chemokine receptors.

[1]  R. Maki,et al.  Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. , 1999, Trends in pharmacological sciences.

[2]  H. Loh,et al.  MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. , 1998, Brain research. Molecular brain research.

[3]  D. Taub,et al.  Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. , 1998 .

[4]  R. B. Chapin,et al.  Morphine Modulates NFκB Activation in Macrophages , 1998 .

[5]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[6]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[7]  T. Eisenstein,et al.  Inhibition of primary murine macrophage cytokine production in vitro following treatment with the K-opioid agonist U50, 488H , 1996, Journal of Neuroimmunology.

[8]  T. Eisenstein,et al.  Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line , 1995, Journal of Neuroimmunology.

[9]  T. Eisenstein,et al.  Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. , 1995, The Journal of pharmacology and experimental therapeutics.

[10]  H. Loh,et al.  Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. , 1995, Biochemical and biophysical research communications.

[11]  L. Yu,et al.  δ-Opioid Receptor Gene Expression in Lymphocytes , 1994 .

[12]  T. Eisenstein,et al.  Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. , 1993, The Journal of pharmacology and experimental therapeutics.

[13]  C. Chen,et al.  Molecular cloning and expression of a rat kappa opioid receptor. , 1993, The Biochemical journal.

[14]  Y. Chen,et al.  Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. , 1993, The Biochemical journal.

[15]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[16]  J. Bidlack,et al.  κ-Opioid binding sites on a murine lymphoma cell line , 1992 .

[17]  D. Blackbourn,et al.  Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. , 1992, The Journal of pharmacology and experimental therapeutics.

[18]  D. Taub,et al.  Immunomodulatory activity of mu- and kappa-selective opioid agonists. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Pert,et al.  The periaqueductal gray matter mediates opiate-induced immunosuppression. , 1989, Science.

[20]  J. Blalock,et al.  Opioid receptors on cells of the immune system: evidence for δ- and κ-classes , 1989 .

[21]  N. Dafny,et al.  Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments , 1986, Experimental Neurology.

[22]  C. Pert,et al.  Opiate receptor-mediated chemotaxis of human monocytes , 1985, Neuropeptides.

[23]  D. V. Van Epps,et al.  Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. , 1984, Journal of immunology.

[24]  E. M. Smith,et al.  Regulation of the in vitro antibody response by neuroendocrine hormones. , 1982, Proceedings of the National Academy of Sciences of the United States of America.